CANNABIS CONSORTIUM HAS SECURED A STEADY SUPPLY OF MEDICAL GRADE
OIL FOR ITS PRODUCTS.
Coconut Creek,
FL -- February 23, 2018 -- InvestorsHub NewsWire
-- Bahamas Development
Corporation (OTCPINK:
BDCI) subsidiary company Cannabis
Consortium, Inc., has partnered with a Cannabis Distillate to
supply all of its Oil needs in California and any other
the State the company has operations in.
When Cannabis
Consortium rolls out its specialty products, the key factor will be a
steady supply of premium oils to be used in its products.
The partner
chosen by Cannabis Oils has the expertise to
assist Cannabis Consortium in creating the right mixture for its
various products. The Cannabis
Distillate offers a diverse variety of Oils, that combined with Cannabis
Consortiums patented delivery method, will provide
for desired effects.
About the Cannabis
Distillate:
They produce 100% solvent-free cannabis distillate
delivering potency, purity and flavor. Their
medical grade oil is extracted from micro-grows and is hand
trimmed. They use state of the art CO2
Supercritical extraction methods preserving the delicate
cannabinoid and full spectrum terpene profile.
About Cannabis Consortium:
Cannabis
Consortium is actively pursuing four (4) revenue streams
in the cannabis
marketplace:
- Specialty items
- Beverages
- Investment
- Research/New
Products
Bahamas
Development Corporation, in compliance with SEC regulations, may in
the future use social media outlets like Facebook or Twitter and
its own website to announce key information in compliance with Reg
FD.
Forward-Looking
Statements
This news
release contains "forward-looking statements" as that term is
defined in Section 27(a) of the United States Securities Act of
1933, as amended and Section 21(e) of the Securities Exchange Act
of 1934, as amended. Statements in this press release which are not
purely historical are forward-looking statements and include any
statements regarding beliefs, plans, expectations or intentions
regarding the future. Such forward-looking statements include,
among other things, estimates of services and
equipment markets, release of corporate apps, growth of platform,
target markets, product releases, product demand and, business
strategy. Actual results could differ
from those projected in any forward-looking statements due to
numerous factors. Such factors include, among others, the inherent
uncertainties associated with new projects and development stage
companies. These forward-looking statements are made as of the date
of this news release, and we assume no obligation to update the
forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans,
expectations and intentions contained in this press release are
reasonable, there can be no assurance that any such beliefs, plans,
expectations or intentions will prove to be accurate. Investors
should consult all of the information set forth herein and should
also consider that any investment
in securities is at risk.
Details of the
Company's business, finances, appointments and agreements can be
found as part of the Company's continuous public disclosure
on otcmarkets.com.
For additional
information about this release please contact:
Investor
Relations:
Matt
Dwyer
matt@cannabisconsortium.net
www.cannabisconsortium.net
954-905-9896